Viewing Study NCT04895761


Ignite Creation Date: 2025-12-24 @ 12:58 PM
Ignite Modification Date: 2025-12-31 @ 4:19 AM
Study NCT ID: NCT04895761
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-10
First Post: 2021-05-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer
Sponsor: Providence Health & Services
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module